Immix Biopharma (IMMX) Enterprise Value (2021 - 2026)
Immix Biopharma's Enterprise Value was $505.43 million in Q2 2026, up 971.7% from $47.16 million a year earlier and up 28.8% from the prior quarter.
Powered by 
Analysis
Immix Biopharma (IMMX) Enterprise Value (2021 - 2026) Analysis & Trends
For FY2025, Enterprise Value at Immix Biopharma came in at $72.01 million, up 67.8% from FY2024.
- In earlier years, Enterprise Value was $42.91 million in FY2024 (-64.3%), $120.15 million in FY2023 (+553.8%), $18.38 million in FY2022 and -$4.57 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Enterprise Value in data going back to Q4 2021.
- Compared with a year earlier, Enterprise Value was higher in four of the last seven quarters, with growth averaging 155.1%.
- The best year-over-year quarter for Enterprise Value over five years was Q2 2026 (growth of 971.7%); the worst was Q4 2024 (a decline of 64.3%).
- Per Business Quant data, IMMX's Enterprise Value in the three quarters before Q2 2026 was $392.34 million (Q1 2026), $72.01 million (Q4 2025) and $53.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Immix Biopharma | 820.51 Mn | 820.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 505.43 Mn |
| Mar 31, 2026 | 392.34 Mn |
| Dec 31, 2025 | 72.01 Mn |
| Sep 30, 2025 | 53.10 Mn |
| Jun 30, 2025 | 47.16 Mn |
| Mar 31, 2025 | 30.87 Mn |
| Dec 31, 2024 | 42.91 Mn |
| Sep 30, 2024 | 21.26 Mn |
| Jun 30, 2024 | 30.33 Mn |
| Mar 31, 2024 | 51.43 Mn |
| Dec 31, 2023 | 120.15 Mn |
| Sep 30, 2023 | 47.35 Mn |
| Jun 30, 2023 | 31.03 Mn |
| Mar 31, 2023 | 13.89 Mn |
| Dec 31, 2022 | 18.38 Mn |
| Sep 30, 2022 | 2.02 Mn |
| Jun 30, 2022 | 17.76 Mn |
| Mar 31, 2022 | 14.34 Mn |
| Dec 31, 2021 | -4.57 Mn |
API Access
Immix Biopharma Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=IMMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "IMMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=IMMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();